About
Xap Therapeutics develops programmable cellular therapies by using genome editing and synthetic biology to engineer immune cells that precisely target diseases such as cancer and autoimmunity.
Explore Xap Therapeutics's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.